Extended knowledge of Phenyl(pyridin-2-yl)methanone

Product Details of 91-02-1. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Rowley, JA; Reid, RC; Poon, EKY; Wu, KC; Lim, JX; Lohman, RJ; Hamidon, JK; Yau, MK; Halili, MA; Durek, T; Iyer, A; Fairlie, DP or concate me.

Recently I am researching about PROTEIN; AGONISTS; LIGANDS; ANAPHYLATOXINS; REGULATORS; C5A, Saw an article supported by the National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1145372, 1084018, 1028423]; Australian Research CouncilAustralian Research Council [DP130100629, DP180103244]; Australian Research Council Centre of Excellence in Advanced Molecular ImagingAustralian Research Council [CE140100011]; Queensland Government (CIF grant); University of QueenslandUniversity of Queensland; UQ Postdoctoral Research Fellowship; [1027369]; [1117017]. Product Details of 91-02-1. Published in AMER CHEMICAL SOC in WASHINGTON ,Authors: Rowley, JA; Reid, RC; Poon, EKY; Wu, KC; Lim, JX; Lohman, RJ; Hamidon, JK; Yau, MK; Halili, MA; Durek, T; Iyer, A; Fairlie, DP. The CAS is 91-02-1. Through research, I have a further understanding and discovery of Phenyl(pyridin-2-yl)methanone

Structure-activity relationships for a series of small-molecule thiophenes resulted in potent and selective antagonism of human Complement C3a receptor. The compounds are about 100-fold more potent than the most reported antagonist SB290157. A new compound JR14a was among the most potent of the new antagonists in vitro, assessed by (a) inhibition of intracellular calcium release (IC50 10 nM) induced in human monocyte-derived macrophages by 100 nM C3a, (b) inhibition of beta-hexosaminidase secretion (IC50 8 nM) from human LAD2 mast cells degranulated by 100 nM C3a, and (c) selectivity for human C3aR over C5aR JR14a was metabolically stable in rat plasma and in rat liver microsomes and efficacious in rats when given orally to suppress rat paw inflammation, macrophage and mast cell activation, and histopathology induced by intraplantar paw administration of a C3aR agonist. Potent C3aR antagonists are now available for interrogating C3a receptor activation and suppressing C3aR-mediated inflammation in mammalian physiology and disease.

Product Details of 91-02-1. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Rowley, JA; Reid, RC; Poon, EKY; Wu, KC; Lim, JX; Lohman, RJ; Hamidon, JK; Yau, MK; Halili, MA; Durek, T; Iyer, A; Fairlie, DP or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem